ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $1.12B

      Shares

      1.51M

      % of Portfolio

      3.27%

      Average Buy Price

      $591

      Avg closing price
      Price range

      8 Tiger Global Lilly(Eli) Trades

      Tiger Global's position in Lilly(Eli) is currently worth $1.12B. That's 3.27% of their equity portfolio (9th largest holding). The first Lilly(Eli) trade was made in Q2 2023. Since then Tiger Global bought shares six more times and sold shares on one occasions. The stake costed the investor $894M, netting the investor a gain of 26% so far.

      Avg closing price
      Price range
      Increased shares by 13.2% (+176k shares) Q2 2025
      Avg closing price $777.40
      Price range $713.71 - $898.95
      Increased shares by 1.9% (+25k shares) Q1 2025
      Avg closing price $829.92
      Price range $725.72 - $929.72
      Increased shares by 35.1% (+340k shares) Q4 2024
      Avg closing price $826.57
      Price range $727.53 - $932.06
      Increased shares by 4.3% (+39.8k shares) Q3 2024
      Avg closing price $899.87
      Price range $772.14 - $960.02
      Increased shares by 4.5% (+40k shares) Q2 2024
      Avg closing price $799.92
      Price range $724.87 - $909.04
      Sold 3.2% shares (-29.1k shares) Q4 2023
      Avg closing price $583.70
      Price range $525.19 - $619.13
      Increased shares by 26.9% (+195k shares) Q3 2023
      Avg closing price $515.29
      Price range $434.70 - $599.30
      New holding (+724k shares) Q2 2023
      Avg closing price $419.37
      Price range $350.74 - $468.98

      News about Lilly(Eli) & Co and Tiger Global

      Lilly to participate in Morgan Stanley 23rd Annual Global Healthcare Conference

      Lilly to participate in Morgan Stanley 23rd Annual Global Healthcare Conference

      INDIANAPOLIS , Aug. 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference...

      prnewswire.com prnewswire.com, 11 days ago
      Lilly's Diabetes Pill Clears Major Trial, Analyst Points To Global Potential

      Lilly's Diabetes Pill Clears Major Trial, Analyst Points To Global Potential

      Eli Lilly And Co? LLY on Thursday reported topline Phase 3 results from ACHIEVE-1 trial of orforglipron compared to placebo in adults with type 2 diabetes an...

      benzinga.com benzinga.com, 5 months ago
      Tesla, Paramount Global, Annovis Bio, Eli Lilly, Amazon: Why These 5 Stocks Are On Investors'' Radars Today

      Tesla, Paramount Global, Annovis Bio, Eli Lilly, Amazon: Why These 5 Stocks Are On Investors'' Radars Today

      On Tuesday, the Dow Jones Industrial Average rose by 0.4%, closing at $39,331.85, while the S&P 500 also ended the day in positive territory, increasing by 0...

      Benzinga Benzinga, about 1 year ago
      Eli Lilly¡¯s double impact: Mounjaro and Donanemab set to outshine market rivals, says GlobalData

      Eli Lilly¡¯s double impact: Mounjaro and Donanemab set to outshine market rivals, says GlobalData

      Eli Lilly and Co is on the brink of reshaping the pharmaceutical landscape with its groundbreaking treatments, Mounjaro (tirzepatide) for obesity and the hig...

      Global Data Global Data, over 1 year ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×